Publications for Kenneth Bradstock
Publications for Kenneth Bradstock
2016
Bryant, C., Fromm, P., Kupresanin, F., Clark, G.,
Lee, K., Clarke, C., Silveira, P., Suen, H.,
Brown, R., Newman, E., Hart, D., et al (2016). A
CD2 high-expressing stress-resistant human
plasmacytoid dendritic-cell subset. Immunology
and Cell Biology, 94(5), 447-457. <a
href="http://dx.doi.org/10.1038/icb.2015.116">[
More Information]</a>
Seldon, T., Pryor, R., Palkova, A., Jones, M.,
Verma, N., Findova, M., Braet, K., Sheng, Y.,
Fan, Y., Zhou, E., Fromm, P., Silveira, P.,
Elgundi, Z., Ju, X., Clark, G., Bradstock, K.,
Hart, D., et al (2016). Immunosuppressive
human anti-CD83 monoclonal antibody
depletion of activated dendritic cells in
transplantation. Leukemia, 30(3), 692-700. <a
href="http://dx.doi.org/10.1038/leu.2015.231">[
More Information]</a>
2015
He, S., Busfield, S., Ritchie, D., Hertzberg, M.,
Durrant, S., Lewis, I., Marlton, P., McLachlan,
A., Kerridge, I., Bradstock, K., Iland, H., et al
(2015). A Phase 1 study of the safety,
pharmacokinetics and anti-leukemic activity of
the anti-CD123 monoclonal antibody CSL360 in
relapsed, refractory or high-risk acute myeloid
leukemia. Leukemia & Lymphoma, 56(5),
1406-1415. <a
href="http://dx.doi.org/10.3109/10428194.2014.
956316">[More Information]</a>
Lickliter, J., Taylor, K., Szer, J., Grigg, A.,
Arthur, C., Hughes, T., Durrant, S., Filshie, R.,
Irving, I., et al, Bradstock, K. (2015). An
imatinib-only window followed by imatinib and
chemotherapy for Philadelphia
chromosome-positive acute leukemia: long-term
results of the CMLALL1 trial. Leukemia &
Lymphoma, 56(3), 630-638. <a
href="http://dx.doi.org/10.3109/10428194.2014.
925547">[More Information]</a>
Bradstock, K., Bilmon, I., Kwan, J., Blyth, E.,
Micklethwaite, K., Huang, G., Deren, S., Byth
Wilson, K., Gottlieb, D. (2015). Influence of
Stem Cell Source on Outcomes of Allogeneic
Reduced Intensity Conditioning Therapy
Transplants Using Haploidentical Related
Donors. Biology of Blood and Marrow
Transplantation, 21(9), 1641-1645. <a
href="http://dx.doi.org/10.1016/j.bbmt.2015.06.0
06">[More Information]</a>
Bradstock, K., Bilmon, I., Kwan, J.,
Micklethwaite, K., Blyth, E., Deren, S., Bayley,
A., Gebski, V., Gottlieb, D. (2015). Single-agent
high-dose cyclophosphamide for
graft-versus-host disease prophylaxis in human
leukocyte antigen-matched reduced-intensity
peripheral blood stem cell transplantation results
in an unacceptably high rate of severe acute
graft-versus-host disease. Biology of Blood and
Marrow Transplantation, 21(5), 941-944. <a
href="http://dx.doi.org/10.1016/j.bbmt.2015.01.0
20">[More Information]</a>
Iland, H., Collins, M., Bradstock, K., Supple, S.,
Catalano, A., Hertzberg, M., Browett, P., Grigg,
A., Firkin, F., Campbell, L., et al (2015). Use of
arsenic trioxide in remission induction and
consolidation therapy for acute promyelocytic
leukaemia in the Australasian Leukaemia and
Lymphoma Group (ALLG) APML4 study: a
non-randomised phase 2 trial. The Lancet
Haematology, 2(9), e357-e366. <a
href="http://dx.doi.org/10.1016/S2352-3026(15)
00115-5">[More Information]</a>
2014
Bradstock, K., Link, E., Collins, M., Di Iulio, J.,
Lewis, I., Schwarer, A., Enno, A., Marlton, P.,
Hahn, U., Szer, J., et al (2014). A randomized
trial of prophylactic palifermin on
gastrointestinal toxicity after intensive induction
therapy for acute myeloid leukaemia. British
Journal of Haematology, 167(5), 618-625. <a
href="http://dx.doi.org/10.1111/bjh.13086">[Mo
re Information]</a>
Gasiorowski, R., Clark, G., Bradstock, K., Hart,
D. (2014). Antibody therapy for acute myeloid
leukaemia. British Journal of Haematology,
164(4), 481-495. <a
href="http://dx.doi.org/10.1111/bjh.12691">[Mo
re Information]</a>
Wong, J., Welschinger, R., Hewson, J.,
Bradstock, K., Bendall, L. (2014). Efficacy of
dual PI-3K and mTOR inhibitors in vitro and in
vivo in acute lymphoblastic leukemia.
Oncotarget, 5(21), 10460-10472.
Bendall, L., Bradstock, K. (2014). G-CSF: From
granulopoietic stimulant to bone marrow stem
cell mobilizing agent. Cytokine & Growth Factor
Reviews, 25(4), 355-367. <a
href="http://dx.doi.org/10.1016/j.cytogfr.2014.07
.011">[More Information]</a>
Baraz, R., Cisterne, A., Saunders, P., Hewson, J.,
Thien, M., Weiss, J., Basnett, J., Bradstock, K.,
Bendall, L. (2014). mTOR inhibition by
everolimus in childhood acute lymphoblastic
leukemia induces caspase-independent cell
death. PloS One, 9(7), 1-10. <a
href="http://dx.doi.org/10.1371/journal.pone.010
2494">[More Information]</a>
Raj, K., Pagliuca, A., Bradstock, K., Noriega, V.,
Potter, V., Streetly, M., McLornan, D., Kazmi,
M., Marsh, J., Kwan, J., et al (2014). Peripheral
Blood Hematopoietic Stem Cells for
Publications for Kenneth Bradstock
Transplantation of Hematological Diseases from
Related, Haploidentical Donors after
Reduced-Intensity Conditioning. Biology of
Blood and Marrow Transplantation, 20(6),
890-895. <a
href="http://dx.doi.org/10.1016/j.bbmt.2014.03.0
03">[More Information]</a>
Ardeshna, K., Qian, W., Smith, P., Braganca, N.,
Lowry, L., Patrick, P., Warden, J., Stevens, L.,
Pocock, C., Bradstock, K., et al (2014).
Rituximab versus a watch-and-wait approach in
patients with advanced-stage, asymptomatic,
non-bulky follicular lymphoma: an open-label
randomised phase 3 trial. The Lancet Oncology,
15(4), 424-435.
Cisterne, A., Baraz, R., Khan, N., Welschinger,
R., Basnett, J., Fung, C., Rizos, H., Bradstock,
K., Bendall, L. (2014). Silencer of death domains
controls cell death through tumour necrosis
factor-receptor 1 and caspase-10 in acute
lymphoblastic leukemia. PloS One, 9(7), 1-10.
<a
href="http://dx.doi.org/10.1371/journal.pone.010
3383">[More Information]</a>
2013
Nivison-Smith, I., Simpson, J., Dodds, A., Ma,
D., Szer, J., Bradstock, K. (2013). A
population-based analysis of the effect of
autologous hematopoietic cell transplant in the
treatment of multiple myeloma. Leukemia &
Lymphoma, 54(8), 1671-1676. <a
href="http://dx.doi.org/10.3109/10428194.2013.
763396">[More Information]</a>
Shahin, K., Sartor, M., Hart, D., Bradstock, K.
(2013). Alterations in Chemokine Receptor
CCR5 Expression on Blood Dendritic Cells
Correlate With Acute Graft-Versus-Host
Disease. Transplantation, 96(8), 753-762. <a
href="http://dx.doi.org/10.1097/TP.0b013e31829
e6d5b">[More Information]</a>
Morrissey, C., Chen, S., Sorrell, T., Milliken, S.,
Bardy, P., Bradstock, K., Szer, J., Halliday, C.,
Gilroy, N., Moore, J., et al (2013).
Galactomannan and PCR versus culture and
histology for directing use of antifungal
treatment for invasive aspergillosis in high-risk
haematology patients: a randomised controlled
trial. The Lancet Infectious Diseases, 13(6),
519-528. <a
href="http://dx.doi.org/10.1016/S1473-3099(13)
70076-8">[More Information]</a>
Bilmon, I., Kwan, J., Gottlieb, D., Kerridge, I.,
McGurgan, M., Huang, G., George, B.,
Hertzberg, M., Bradstock, K. (2013).
Haploidentical bone marrow transplants for
hematological malignancies using
non-myeloablative conditioning therapy and
post-transplant immunosuppression with
cyclophosphamide: results from a single
Australian centre. Internal Medicine Journal,
43(2), 191-196. <a
href="http://dx.doi.org/10.1111/j.1445-5994.201
2.02843.x">[More Information]</a>
Wallington-Beddoe, C., Bradstock, K., Bendall,
L. (2013). Oncogenic properties of sphingosine
kinases in haematological malignancies. British
Journal of Haematology, 161(5), 623-638. <a
href="http://dx.doi.org/10.1111/bjh.12302">[Mo
re Information]</a>
Welschinger, R., Liedtke, F., Basnett, J., Dela
Pena, A., Juarez, J., Bradstock, K., Bendall, L.
(2013). Plerixafor (AMD3100) induces
prolonged mobilization of acute lymphoblastic
leukemia cells and increases the proportion of
cycling cells in the blood in mice. Experimental
Hematology, 41(3), 293-302.e1. <a
href="http://dx.doi.org/10.1016/j.exphem.2012.1
1.004">[More Information]</a>
Heatley, S., Pietra, G., Lin, J., Widjaja, J.,
Harpur, C., Lester, S., Rossjohn, J., Szer, J.,
Schwarer, A., Bradstock, K., et al (2013).
Polymorphism in Human Cytomegalovirus UL40
Impacts on Recognition of Human Leukocyte
Antigen-E (HLA-E) by Natural Killer Cells. The
Journal of Biological Chemistry, 288(12),
8679-8690. <a
href="http://dx.doi.org/10.1074/jbc.M112.40967
2">[More Information]</a>
Saunders, P., Weiss, J., Welschinger, R., Baraz,
R., Bradstock, K., Bendall, L. (2013). RAD001
(everolimus) induces dose-dependent changes to
cell cycle regulation and modifies the cell cycle
response to vincristine. Oncogene, 32(40),
4789-4797. <a
href="http://dx.doi.org/10.1038/onc.2012.498">[
More Information]</a>
2012
George, B., Kerridge, I., Gilroy, N., Huang, G.,
Hertzberg, M., Bradstock, K., Gottlieb, D.
(2012). A risk score for early cytomegalovirus
reactivation after allogeneic stem cell
transplantation identifies low-, intermediate-, and
high-risk groups: reactivation risk is increased by
graft-versus-host disease only in the
intermediate-risk group. Transplant Infectious
Disease (Print), 14(2), 141-148. <a
href="http://dx.doi.org/10.1111/j.1399-3062.201
1.00706.x">[More Information]</a>
Iland, H., Bradstock, K., Supple, S., Catalano,
A., Collins, M., Hertzberg, M., Browett, P.,
Grigg, A., Firkin, F., Hugman, A., et al (2012).
All-trans-retinoic acid, idarubicin, and IV arsenic
trioxide as initial therapy in acute promyelocytic
leukemia (APML4). Blood, 120(8), 1570-1580.
<a
href="http://dx.doi.org/10.1182/blood-2012-02-4
Publications for Kenneth Bradstock
10746">[More Information]</a>
Nivison-Smith, I., Dodds, A., Butler, J.,
Bradstock, K., Ma, D., Simpson, J., Szer, J.
(2012). Allogeneic Hematopoietic Cell
Transplantation for Chronic Myelofibrosis in
Australia and New Zealand: Older Recipients
Receiving Myeloablative Conditioning at
Increased Mortality Risk. Biology of Blood and
Marrow Transplantation, 18(2), 302-308. <a
href="http://dx.doi.org/10.1016/j.bbmt.2011.05.0
03">[More Information]</a>
Harun, N., Bradstock, K., Bendall, L. (2012).
Combination Strategies for Stem Cell
Mobilization Targeting CXCR4 and S1P
Receptors. In Stefan Fruehauf, W. Jens Zeller
and Gary Calandra (Eds.), Novel Developments
in Stem Cell Mobilization, (pp. 37-54). New
York: Springer Science+Business Media.
Wallington-Beddoe, C., Don, A., Hewson, J.,
Qiao, Q., Papa, R., Lock, R., Bradstock, K.,
Bendall, L. (2012). Disparate In Vivo Efficacy of
FTY720 in Xenograft Models of Philadelphia
Positive and Negative B-lineage Acute
Lymphoblastic Leukemia. PloS One, 7(5), 1-7.
<a
href="http://dx.doi.org/10.1371/journal.pone.003
6429">[More Information]</a>
Khan, N., Cisterne, A., Baraz, R., Bradstock, K.,
Bendall, L. (2012). Para-NO-aspirin inhibits
NF-kB and induces apoptosis in B-cell
progenitor acute lymphoblastic leukemia.
Experimental Hematology, 40(3), 207-215.e1. <a
href="http://dx.doi.org/10.1016/j.exphem.2011.1
1.001">[More Information]</a>
Iland, H., Bradstock, K., Seymour, J., Hertzberg,
M., Grigg, A., Taylor, K., Catalano, J., Cannell,
P., Horvath, N., Deveridge, S., et al (2012).
Results of the APML3 trial incorporating
all-trans-retinoic acid and idarubicin in both
induction and consolidation as initial therapy for
patients with acute promyelocytic leukemia.
Haematologica, 97(2), 227-234. <a
href="http://dx.doi.org/10.3324/haematol.2011.0
47506">[More Information]</a>
van der Jagt, A., Muirhead, J., Seymour, J.,
Bradstock, K., Paul, E., Wei, A. (2012). Risk
factors for early death after high-dose cytosine
arabinoside (HiDAC)-based chemotherapy for
adult AML. Leukemia, 26(2), 362-365. <a
href="http://dx.doi.org/10.1038/leu.2011.201">[
More Information]</a>
Juarez, J., Harun, N., Thien, M., Welschinger,
R., Baraz, R., Dela Pena, A., Pitson, S., Rettig,
M., DiPersio, J., Bradstock, K., Bendall, L.
(2012). Sphingosine-1-phosphate facilitates
trafficking of hematopoietic stem cells and their
mobilization by CXCR4 antagonists in mice.
Blood, 119(3), 707-716. <a
href="http://dx.doi.org/10.1182/blood-2011-04-3
48904">[More Information]</a>
2011
Nivison-Smith, I., Dodds, A., Doocey, R., Ganly,
P., Gibson, J., Ma, D., Simpson, J., Szer, J.,
Bradstock, K., Bradstock, K. (2011). Allogeneic
hematopoietic cell transplant for multiple
myeloma using reduced intensity conditioning
therapy, 1998-2006: factors associated with
improved survival outcome. Leukemia &
Lymphoma, 52(9), 1727-1735. <a
href="http://dx.doi.org/10.3109/10428194.2011.
582201">[More Information]</a>
Fromm, P., Gottlieb, D., Bradstock, K., Hart, D.
(2011). Cellular therapy to treat haematological
and other malignancies: progress and pitfalls.
Pathology, 43(6), 605-615. <a
href="http://dx.doi.org/10.1097/PAT.0b013e328
34b6b24">[More Information]</a>
Morrissey, C., Chen, S., Sorrell, T., Bradstock,
K., Szer, J., Halliday, C., Gilroy, N., Schwarer,
A., Slavin, M. (2011). Design issues in a
randomized controlled trial of a pre-emptive
versus empiric antifungal strategy for invasive
aspergillosis in patients with high-risk
hematologic malignancies. Leukemia &
Lymphoma, 52(2), 179-193. <a
href="http://dx.doi.org/10.3109/10428194.2010.
542600">[More Information]</a>
Wallington-Beddoe, C., Hewson, J., Bradstock,
K., Bendall, L. (2011). FTY720 produces
caspase-independent cell death of acute
lymphoblastic leukemia cells. Autophagy, 7(7),
707-715. <a
href="http://dx.doi.org/10.4161/auto.7.7.15154">
[More Information]</a>
Nivison-Smith, I., Dodds, A., Dunckley, H., Ma,
D., Moore, J., Simpson, J., Szer, J., Bradstock,
K. (2011). Increased activity and improved
outcome in unrelated donor haemopoietic cell
transplants for acute myeloid leukaemia in
Australia, 1992-2005. Internal Medicine Journal,
41(1A), 27-34. <a
href="http://dx.doi.org/10.1111/j.1445-5994.201
0.02262.x">[More Information]</a>
Bray, L., Jordens, C., Rowlings, P., Bradstock,
K., Kerridge, I. (2011). The long haul: Caring for
bone marrow transplant patients in regional
Australia. Australian Journal of Advanced
Nursing, 29(1), 5-13.
Saunders, P., Cisterne, A., Weiss, J., Bradstock,
K., Bendall, L. (2011). The mammalian target of
rapamycin inhibitor RAD001 (everolimus)
synergizes with chemotherapeutic agents,
ionizing radiation and proteasome inhibitors in
pre-B acute lymphocytic leukemia.
Haematologica, 96(1), 69-77. <a
Publications for Kenneth Bradstock
href="http://dx.doi.org/10.3324/haematol.2010.0
26997">[More Information]</a>
2010
Murray, P., Kerridge, I., Tiley, C., Catanzariti,
A., Welberry, H., Lean, C., Sinclair, S., Bishop,
J., Bradstock, K. (2010). Enrolment of patients to
clinical trials in haematological cancer in New
South Wales: Current status, perceived barriers
and opportunities for improvement. Internal
Medicine Journal, 40(2), 133-138. <a
href="http://dx.doi.org/10.1111/j.1445-5994.200
9.01911.x">[More Information]</a>
George, B., Kerridge, I., Gilroy, N., Huang, G.,
Hertzberg, M., Gottlieb, D., Bradstock, K.
(2010). Fludarabine-based reduced intensity
conditioning transplants have a higher incidence
of cytomegalovirus reactivation compared with
myeloablative transplants. Bone Marrow
Transplantation, 45(5), 849-855. <a
href="http://dx.doi.org/10.1038/bmt.2009.273">[
More Information]</a>
George, B., Pati, N., Gilroy, N., Ratnamohan,
M., Huang, G., Kerridge, I., Hertzberg, M.,
Gottlieb, D., Bradstock, K. (2010). Pre-transplant
cytomegalovirus (CMV) serostatus remains the
most important determinant of CMV reactivation
after allogeneic hematopoietic stem cell
transplantation in the era of surveillance and
preemptive therapy. Transplant Infectious
Disease (Print), 12(4), 322-329. <a
href="http://dx.doi.org/10.1111/j.1399-3062.201
0.00504.x">[More Information]</a>
2009
Spencer, A., Prince, H., Roberts, A., Prosser, I.,
Bradstock, K., Coyle, L., Gill, D., Horvath, N.,
Reynolds, J., Kennedy, N. (2009). Consolidation
Therapy With Low-Dose Thalidomide and
Prednisolone Prolongs the Survival of Multiple
Myeloma Patients Undergoing a Single
Autologous Stem-Cell Transplantation
Procedure. Journal of Clinical Oncology, 27(11),
1788-1793. <a
href="http://dx.doi.org/10.1200/JCO.2008.18.85
73">[More Information]</a>
Juarez, J., Thien, M., Dela Pena, A., Baraz, R.,
Bradstock, K., Bendall, L. (2009). CXCR4
mediates the homing of B cell progenitor acute
lymphoblastic leukaemia cells to the bone
marrow via activation of p38MAPK. British
Journal of Haematology, 145, 491-499. <a
href="http://dx.doi.org/10.1111/j.1365-2141.200
9.07648.x">[More Information]</a>
Brooke, G., Rossetti, T., Pelekanos, R., Ilic, N.,
Murray, P., Hancock, S., Antonenas, V., Huang,
G., Gottlieb, D., Bradstock, K., et al (2009).
Manufacturing of human placenta-derived
mesenchymal stem cells for clinical trials. British
Journal of Haematology, 144(4), 571-579. <a
href="http://dx.doi.org/10.1111/j.1365-2141.200
8.07492.x">[More Information]</a>
Deo, S., Bradstock, K., Bendall, L. (2009).
p38MAPK inhibitors attenuate cytokine
production by bone marrow stromal cells and
reduce stroma-mediated proliferation of acute
lymphoblastic leukemia cells. Cell Cycle, 8(18),
2977-2985. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19713744">[More Information]</a>
Ferguson, P., Sorrell, T., Bradstock, K., Carr, P.,
Gilroy, N. (2009). Parainfluenza Virus Type 3
Pneumonia in Bone Marrow Transplant
Recipients: Multiple Small Nodules in
High-Resolution Lung Computed Tomography
Scans Provide a Radiological Clue to Diagnosis.
Clinical Infectious Diseases, 48(7), 905-909. <a
href="http://dx.doi.org/10.1086/597297">[More
Information]</a>
Crazzolara, R., Cisterne, A., Thien, M., Hewson,
J., Baraz, R., Bradstock, K., Bendall, L. (2009).
Potentiating effects of RAD001 (Everolimus) on
vincristine therapy in childhood acute
lymphoblastic leukemia. Blood, 113(14),
3297-3306. <a
href="http://dx.doi.org/10.1182/blood-2008-02-1
37752">[More Information]</a>
Crazzolara, R., Bradstock, K., Bendall, L.
(2009). RAD001 (Everolimus) induces
autophagy in acute lymphoblastic leukemia.
Autophagy, 5(5), 727-728. <a
href="http://dx.doi.org/10.4161/auto.5.5.8507">[
More Information]</a>
Nivison-Smith, I., Simpson, J., Dodds, A., Ma,
D., Szer, J., Bradstock, K. (2009). Relative
Survival of Long-Term Hematopoietic Cell
Transplant Recipients Approaches General
Population Rates. Biology of Blood and Marrow
Transplantation, 15(10), 1323-1330. <a
href="http://dx.doi.org/10.1016/j.bbmt.2009.06.0
14">[More Information]</a>
Bradstock, K., Hertzberg, M., Kerridge, I.,
Svennilson, J., George, B., McGurgan, M.,
Huang, G., Antonenas, V., Gottlieb, D. (2009).
Single versus double unrelated umbilical cord
blood units for allogeneic transplantation in
adults with advanced hematological
malignancies: a retrospective comparison of
outcomes. Internal Medicine Journal, 39(11),
744-751. <a
href="http://dx.doi.org/10.1111/j.1445-5994.200
8.01825.x">[More Information]</a>
2008
George, B., Kerridge, I., Gottlieb, D., Huang, G.,
Hertzberg, M., Svennilson, J., Bradstock, K.
Publications for Kenneth Bradstock
(2008). A reduced intensity conditioning
protocol associated with excellent survival in
patients with myelofibrosis. Bone Marrow
Transplantation, 42(8), 567-568. <a
href="http://dx.doi.org/10.1038/bmt.2008.219">[
More Information]</a>
Pati, N., Garvin, F., Antonenas, V., Kerridge, I.,
Bradstock, K., Gottlieb, D. (2008). Best
Approach for Harvesting Bone Marrow to
Maximize TNC and CD34+ Cell Counts. 50th
American Society of Hematology Annual
Meeting and Exposition ASH 2008, United
States: American Society of Hematology.
Bradstock, K. (2008). Can the influence of
karyotype in acute myeloid leukemia be
overcome by high-dose chemotherapy?
Leukemia & Lymphoma, 49(12), 2227-2228. <a
href="http://dx.doi.org/10.1080/1042819080250
6628">[More Information]</a>
Khan, N., Cisterne, A., Devidas, M., Shuster, J.,
Hunger, S., Shaw, P., Bradstock, K., Bendall, L.
(2008). Expression of CD44, but not CD44v6,
predicts relapse in children with B cell
progenitor acute lymphoblastic leukemia lacking
adverse or favorable genetics. Leukemia and
Lymphoma, 49(4), 710-718. <a
href="http://dx.doi.org/10.1080/1042819070186
1660">[More Information]</a>
Mullighan, C., Heatley, S., Danner, S., Dean, M.,
Doherty, K., Hahn, U., Bradstock, K.,
Minchinton, R., Schwarer, A., Szer, J., et al
(2008). Mannose-binding lectin status is
associated with risk of major infection following
myeloablative sibling allogeneic hematopoietic
stem cell transplantation. Blood, 112(5),
2120-2128. <a
href="http://dx.doi.org/10.1182/blood-2007-07-1
00222">[More Information]</a>
Micklethwaite, K., Clancy, L., Sandher, U.,
Hansen, A., Blyth, E., Antonenas, V., Sartor, M.,
Bradstock, K., Gottlieb, D. (2008). Prophylactic
infusion of cytomegalovirus specific cytotoxic
T-lymphocytes stimulated with Ad5f35pp65
gene modified dendritic cells following
allogeneic haemopoietic stem cell
transplantation. Blood, 112(10), 3974-3981. <a
href="http://dx.doi.org/10.1182/blood-2008-06-1
61695">[More Information]</a>
George, B., Kerridge, I., Huang, G., Gottlieb, D.,
Hertzberg, M., Bradstock, K. (2008). Use of
Reduced Intensity Conditioning (RIC) Regimens
Are Associated with a Better Outcome with
Sibling Donors Transplants in Older Patients (>
50 years) with Acute Myeloid Leukemia (AML).
50th American Society of Hematology Annual
Meeting and Exposition ASH 2008, United
States: American Society of Hematology.
2007
Grigg, A., Gibson, J., Bardy, P., Reynolds, J.,
Shuttleworth, P., Koelmeyer, R., Szer, J.,
Roberts, A., To, L., Kennedy, G., Bradstock, K.
(2007). A prospective multicenter trial of
peripheral blood stem cell sibling allografts for
acute myeloid leukemia in first complete
remission using fludarabine-cyclophosphamide
reduced intensity conditioning. Biology of Blood
and Marrow Transplantation, 13(5), 560-567. <a
href="http://dx.doi.org/10.1016/j.bbmt.2006.12.4
49">[More Information]</a>
Lau, J., Sartor, M., Bradstock, K., Vuckovic, S.,
Munster, D., Hart, D. (2007). Activated
circulating dendritic cells after hematopoietic
stem cell transplantation predict acute
graft-versus-host disease. Transplantation, 83(7),
839-846. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17460553">[More Information]</a>
Khan, N., Bradstock, K., Bendall, L. (2007).
Activation of Wnt/beta-catenin pathway
mediates growth and survival in B-cell
progenitor acute lymphoblastic leukaemia.
British Journal of Haematology, 138(3),
338-348. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17614820">[More Information]</a>
Juarez, J., Dela Pena, A., Baraz, R., Hewson, J.,
Khoo, M., Cisterne, A., Fricker, S., Fujii, N.,
Bradstock, K., Bendall, L. (2007). CXCR4
antagonists mobilize childhood acute
lymphoblastic leukemia cells into the peripheral
blood and inhibit engraftment. Leukemia, 21(6),
1249-1257. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17410186">[More Information]</a>
Moore, J., Nivison-Smith, I., Goh, K., Ma, D.,
Bradstock, K., Szer, J., Durrant, S., Schwarer,
A., Bardy, P., Herrmann, R., et al (2007).
Equivalent survival for sibling and unrelated
donor allogeneic stem cell transplantation for
acute myelogenous leukemia. Biology of Blood
and Marrow Transplantation, 13(5), 601-607. <a
href="http://dx.doi.org/10.1016/j.bbmt.2007.01.0
73">[More Information]</a>
Micklethwaite, K., Hansen, A., Foster, A.,
Snape, E., Antonenas, V., Sartor, M., Shaw, P.,
Bradstock, K., Gottlieb, D. (2007). Ex vivo
expansion and prophylactic infusion of
CMV-pp65 peptide-specific cytotoxic
T-lymphocytes following allogeneic
hematopoietic stem cell transplantation. Biology
of Blood and Marrow Transplantation, 13(6),
707-714. <a
href="http://dx.doi.org/10.1016/j.bbmt.2007.02.0
04">[More Information]</a>
Publications for Kenneth Bradstock
Sartor, M., Garvin, F., Antonenas, V., Bradstock,
K., Gottlieb, D. (2007). Failure to achieve a
threshold dose of CD34(+)CD110(+) progenitor
cells in the graft predicts delayed platelet
engraftment after autologous stem cell
transplantation. Bone Marrow Transplantation,
40(9), 851-857. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17704793">[More Information]</a>
Nivison-Smith, I., Bradstock, K., Dodds, A.,
Hawkins, P., Ma, D., Moore, J., Simpson, J.,
Szer, J. (2007). Hematopoietic stem cell
transplantation in Australia and New Zealand,
1992-2004. Biology of Blood and Marrow
Transplantation, 13(8), 905-912. <a
href="http://dx.doi.org/10.1016/j.bbmt.2007.04.0
03">[More Information]</a>
Juarez, J., Baraz, R., Deo, S., Bradstock, K.,
Bendall, L. (2007). Interaction of interleukin-7
and interleukin-3 with the CXCL12-induced
proliferation of B-cell progenitor acute
lymphoblastic leukemia. Haematologica, 92(4),
450-459. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17488655">[More Information]</a>
Tavernier, E., Boiron, J., Huguet, F., Bradstock,
K., Vey, N., Kovacsovics, T., Delannoy, A.,
Fegueux, N., Fenaux, P., Stamatoullas, A., et al
(2007). Outcome of treatment after first relapse
in adults with acute lymphoblastic leukemia
initially treated by the LALA-94 trial. Leukemia,
21(9), 1907-1914. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17611565">[More Information]</a>
Gottlieb, D., Micklethwaite, K., Bradstock, K.,
Li, Y. (2007). Rapid expansion of tumor-reactive
cells from HLA-matched siblings for adoptive
immunotherapy of melanoma. Cytotherapy, 9(2),
133-143. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17453965">[More Information]</a>
Feyler, S., Prince, H., Pearce, R., Towlson, K.,
Nivison-Smith, I., Schey, S., Gibson, J., Patton,
N., Bradstock, K., Marks, D., et al (2007). The
role of high-dose therapy and stem cell rescue in
the management of T-cell malignant lymphomas:
a BSBMT and ABMTRR study. Bone Marrow
Transplantation, 40(5), 443-450. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17589529">[More Information]</a>
2006
Sartor, M., Antonenas, V., Bradstock, K.,
Gottlieb, D. (2006). Absolute number of
transplanted CD34(+) cells expressing C-MPL
(CD110) correlates with speed of platelet
engraftment following autologous stem cell
transplantation. 2nd International Conference
'Strategies in Tissue Engineering', United
Kingdom: Informa Healthcare.
Hill, G., Morris, E., Fuery, M., Hutchins, C.,
Butler, J., Grigg, A., Roberts, A., Bradstock, K.,
Szer, J., Kennedy, G., et al (2006). Allogeneic
stem cell transplantation with peripheral blood
stem cells mobilized by pegylated G-CSF.
Biology of Blood and Marrow Transplantation,
12(6), 603-607. <a
href="http://dx.doi.org/10.1016/j.bbmt.2006.03.0
01">[More Information]</a>
Belov, L., Mulligan, S., Barber, N., Woolfson,
A., Scott, M., Stoner, K., Chrisp, J., Sewell, W.,
Bradstock, K., Bendall, L., Sartor, M., Young,
G., Wiley, J., Christopherson, R., et al (2006).
Analysis of human leukaemias and lymphomas
using extensive immunophenotypes from an
antibody microarray. British Journal of
Haematology, 135(2), 184-97. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16939496">[More Information]</a>
Dhedin, N., Dombret, H., Thomas, X., Lheritier,
V., Boiron, J., Rigal-Huguet, F., Vernant, J.,
Kuentz, M., Reman, O., Bradstock, K., et al
(2006). Autologous stem cell transplantation in
adults with acute lymphoblastic leukemia in first
complete remission: analysis of the
LALA-85,-87 and-94 trials. Leukemia, 20(2),
336-344.
Bradstock, K. (2006). Chemotherapy for patients
with acute myeloid leukemia in first remission.
Current Hematologic Malignancy Reports, 1(2),
108-113. <a
href="http://dx.doi.org/10.1007/s11899-006-002
1-8">[More Information]</a>
Antonenas, V., Bradstock, K., Shaw, P., Gottlieb,
D. (2006). Comparison between TNC and
CD34+cell counts reported pre-cryopreservation
of unrelated cord blood (UCB) units and those
observed at the time of their transplantation.
2nd International Conference 'Strategies in
Tissue Engineering', United Kingdom: Informa
Healthcare.
Bradstock, K., Lau, J., Sartor, M., Vuckovic, S.,
Munster, D., Hart, D. (2006). Detection of
activated circulating CD11c(+) dendritic cells
using CMRF44 antibody is closely associated
with the severity of acute gvhd after allogeneic
hemopoietic stem cell transplant.
2nd International Conference 'Strategies in
Tissue Engineering', United Kingdom: Informa
Healthcare.
Hansen, A., Micklethwaite, K., Foster, A.,
Publications for Kenneth Bradstock
Bradstock, K., Gottlieb, D. (2006). Ex vivo
expansion of clinical grade CMV specific CTL
for therapeutic use in allogeneic haemopoietic
stem cell transplantation. 2nd International
Conference 'Strategies in Tissue Engineering',
United Kingdom: Informa Healthcare.
Lau, J., Sartor, M., Vuckovic, S., Munster, D.,
Bradstock, K., Hart, D. (2006). Expression of
activation marker, CMRF-44, on blood
CD11c(hi) dendritic cells is closely associated
with the severity of acute gvhd after allogeneic
haematopoietic stem cell transplant. Immunology
and Cell Biology, 84(3), A9-A9.
Antonenas, V., Garvin, F., Webb, M., Sartor, M.,
Bradstock, K., Gottlieb, D. (2006). Fresh PBSC
harvests, but not BM, show temperature-related
loss of CD34 viability during storage and
transport. Cytotherapy, 8(2), 158-165. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16698689">[More Information]</a>
Gottlieb, D., Li, Y., Lionello, I., Tanzarella, S.,
Marangolo, M., Bradstock, K., Russo, V.,
Traversari, C. (2006). Generation of
tumour-specific cytotoxic T-cell clones from
histocompatibility leucocyte antigen-identical
siblings of patients with melanoma. British
Journal of Cancer, 95(2), 181-188. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16819544">[More Information]</a>
Antonenas, V., Garvin, F., Sartor, M., Bradstock,
K., Gottlieb, D. (2006). Optimum temperature
for maintaining the viability of CD34+cells
during storage and transport of fresh
haematopoietic progenitor cells. 32nd Annual
Meeting of the American Society for Blood and
Marrow Transplantation, United States: Elsevier
Ltd.
Hertzberg, M., Crombie, C., Benson, W., Taper,
J., Gottlieb, D., Bradstock, K. (2006). Outpatient
fractionated ifosfamide, carboplatin and
etoposide as salvage therapy in relapsed and
refractory non-Hodgkin's and Hodgkin's
lymphoma. Annals of Oncology, 17 Suppl 4,
iv25-iv30. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16702181">[More Information]</a>
Grigg, A., Shuttleworth, P., Reynolds, J.,
Schwarer, A., Szer, J., Bradstock, K., Hui, C.,
Herrmann, R., Ebeling, P. (2006). Pamidronate
reduces bone loss after allogeneic stem cell
transplantation. Journal of Clinical
Endocrinology and Metabolism, 91(10),
3835-3843. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16835281">[More Information]</a>
Hertzberg, M., Grigg, A., Gottlieb, D., Szer, J.,
Roberts, A., Hoyt, R., Huang, G., Bradstock, K.
(2006). Reduced-intensity allogeneic
haemopoietic stem cell transplantation induces
durable responses in patients with chronic
B-lymphoproliferative disorders. Bone Marrow
Transplantation, 37(10), 923-928. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16565735">[More Information]</a>
Halliday, C., Hoile, R., Sorrell, T., James, G.,
Yadav, S., Shaw, P., Bleakley, M., Bradstock,
K., Chen, S. (2006). Role of prospective
screening of blood for invasive aspergillosis by
polymerase chain reaction in febrile neutropenic
recipients of haematopoietic stem cell transplants
and patients with acute leukaemia. British
Journal of Haematology, 132(4), 478-486. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16412020">[More Information]</a>
Crowther, H., Collins, D., Antonenas, V.,
McGurgan, M., Kerridge, I., Gottlieb, D.,
Bradstock, K. (2006). Successful autologous
peripheral blood stem cell harvest and transplant
in a patient with cold agglutinins. Bone Marrow
Transplantation, 37(3), 329-330. <a
href="http://dx.doi.org/10.1038/sj.bmt.1705232"
>[More Information]</a>
Crowther, H., Collins, D., Antonenas, V.,
McGurgan, M., Kerridge, I., Gottlieb, D.,
Bradstock, K. (2006). Successful autologous
peripheral blood stem cell harvest and transplant
in a patient with cold agglutinins. Bone Marrow
Transplantation, 37(3), 329-330.
Bradstock, K., Hertzberg, M., Kerridge, I.,
Svennilson, J., McGurgan, M., Huang, G.,
Antonenas, V., Gottlieb, D. (2006). Unrelated
umbilical cord blood transplantation for adults
with haematological malignancies: results from a
single Australian centre. Internal Medicine
Journal, 36(6), 355-361. <a
href="http://dx.doi.org/10.1111/j.1445-5994.200
6.01079.x">[More Information]</a>
2005
Bradstock, K., Matthews, J., Lowenthal, R.,
Baxter, H., Catalano, J., Brighton, T., Gill, D.,
Eliadis, P., Joshua, D., Cannell, P., Koutts, J.,
Young, G., et al (2005). A randomized trial of
high- versus conventional-dose cytarabine in
consolidation chemotherapy for adult de novo
acute myeloid leukemia in first remission after
induction therapy containing high-dose
cytarabine. Blood, 105(2), 481-488.
Sader, M., McGrath, K., Hill, M., Bradstock, K.,
Jimenez, M., Handelsman, D., Celermajer, D.,
Publications for Kenneth Bradstock
Heather, A. (2005). Androgen receptor gene
expression in leucocytes is
hormonally regulated: implications for gender
differences in disease pathogenesis. Clinical
Endocrinology, 62(1), 56-63. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15638871">[More Information]</a>
Juarez, J., Hewson, J., Cisterne, A., Baraz, R.,
Bradstock, K., Bendall, L. (2005). CXCR4
antagonists mobilize acute lymphoblastic
leukemia cells into the peripheral blood and
inhibit engraftment in mice. 47th Annual
Meeting of the American Society of Hematology
(ASH), United States: American Society of
Hematology.
Bendall, L., Baraz, R., Juarez, J., Shen, W.,
Bradstock, K. (2005). Defective p38
mitogen-activated protein kinase signaling
impairs chemotaxic but not proliferative
responses to stromal-derived factor-1alpha in
acute lymphoblastic leukemia. Cancer Research.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15833862">[More Information]</a>
Gottlieb, D., Hansen, A., Micklethwaite, K.,
Foster, A., Turtle, C., Antonenas, V., Sartor, M.,
Bradstock, K. (2005). Ex-vivo expansion and
prophylactic infusion of CMV pp65 specific
CTL following haemopoietic stem cell
transplantation (HSCT). 47th Annual Meeting of
the American Society of Hematology (ASH),
United States: American Society of Hematology.
Schmitz, N., Beksac, M., Bacigalupo, A., Ruutu,
T., Nagler, A., Gluckman, E., Russell, N.,
Apperley, J., Szer, J., Bradstock, K., et al (2005).
Filgrastim-mobilized peripheral blood progenitor
cells versus bone marrow transplantation for
treating leukemia: 3-year results from the EBMT
randomized trial. Haematologica, 90(5),
643-648. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15921379">[More Information]</a>
Campana, D., Iwamoto, D., Bendall, L.,
Bradstock, K. (2005). Growth requirements and
immunophenotype of acute lymphoblastic
leukemia progenitors. Blood, 105(10), 4150. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15867424">[More Information]</a>
Nivison-Smith, I., Bradstock, K., Dodds, A.,
Hawkins, P., Szer, J. (2005). Haemopoietic stem
cell transplantation in Australia and New
Zealand, 1992-2001: progress report from the
Australasian Bone Marrow Transplant Recipient
Registry. Internal Medicine Journal, 35(1),
18-27. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15667464">[More Information]</a>
Favaloro, E., Bonar, R., Kershaw, G., Sioufi, J.,
Thom, J., Baker, R., Hertzberg, M., Street, A.,
Lloyd, J., Marsden, K., Hewson, J., Bradstock,
K., Sartor, M., Wong, S., Fulcher, D., et al
(2005). Laboratory diagnosis of von Willebrand
disorder: use of multiple functional assays
reduces diagnostic error rates. Laboratory
Hematology, 11(2), 91-97. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16024332">[More Information]</a>
Bradstock, K. (2005). Lymphoma: the good, the
bad and the ugly. Medicine Today, 6(9), 25-33.
Bendall, L., Bradstock, K. (2005). New therapies
targeting chemokine receptors: Can changing the
way cells traffic be used to treat human disease?
Current Topics in Membranes, 55, 331-365.
Barton, G., Forrester, K., Bradstock, K., Gottlieb,
D., Foster, A. (2005). Optimizing bioreactor
productivity for therapeutic immune cells. Food
and Bioproducts Processing, 83(C2), 158-163.
Antonenas, V., Garvin, F., Webb, M., Sartor, M.,
Bradstock, K., Gottlieb, D. (2005). Optimum
temperature for maintaining the viability or
CD34+cells during storage and transport of fresh
hemopoietic progenitor cells. 47th Annual
Meeting of the American Society of Hematology
(ASH), United States: American Society of
Hematology.
Antonenas, V., Garvin, F., Webb, M., Bradstock,
K. (2005). Optimum temperature for the storage
and transport of fresh haemopoetic progenitor
cells. 31st Annual Meeting of the European
Group for Blood and Marrow Transplantation
(EMBT), London: Nature Publishing Group.
Sartor, M., Antonenas, V., Garvin, F., Webb, M.,
Bradstock, K. (2005). Recovery of viable CD34þ
cells from cryopreserved hemopoietic progenitor
cell products. Bone Marrow Transplantation,
36(3), 199-204. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15937512">[More Information]</a>
Khan, N., Bradstock, K., Bendall, L. (2005). The
Wnt/beta-catenin pathway promotes growth and
survival of acute lymphoblastic leukaemia (ALL)
cells in vitro. 47th Annual Meeting of the
American Society of Hematology (ASH), United
States: American Society of Hematology.
2004
Foster, A., Bradstock, K., Sili, U., Marangolo,
M., Rooney, C., Gottlieb, D. (2004). A
Publications for Kenneth Bradstock
Comparison Of Gene Transfer And
Antigen-Loaded Dendritic Cells For The
Generation Of Cd4+ And Cd8+
Cytomegalovirus-Specific T Cells In Hla-A2+
And Hla-A2- Donors. Biology of Blood and
Marrow Transplantation, 10(11), 761-771. <a
href="http://dx.doi.org/10.1016/j.bbmt.2004.05.0
11">[More Information]</a>
Bradstock, K. (2004). Adult leukaemias:
prognostic classification and treatment. Medicine
Today, 5(5), 41-47.
Juarez, J., Bendall, L., Bradstock, K. (2004).
Chemokines And Their Receptors As
Therapeutic Targets: The Role Of The
Sdf-1/Cxcr4 Axis. Current Pharmaceutical
Design, 10(11), 1245-1259.
Antonenas, V., Kerridge, I., Thomson, A.,
Trickett, A., Shaw, P., Bradstock, K. (2004).
Development of a policy for the storage and
disposal of cryopreserved haematopoietic
progenitor cells for the NSW BMT Network
Laboratories. Australian and New Zealand
Transplant Society.
McGowan, E., Saad, S., Bendall, L., Bradstock,
K., Clarke, C. (2004). Effect Of Progesterone
Receptor A Predominance On Breast Cancer Cell
Migration Into Bone Marrow Fibroblasts. Breast
Cancer Research and Treatment, 83(3), 211-220.
Foster, A., Marangolo, M., Sartor, M.,
Alexander, S., Hu, M., Bradstock, K., Gottlieb,
D. (2004). Human Cd62L- Memory T Cells Are
Less Responsive To Alloantigen Stimulation
Than Cd62L+ Naive T Cells: Potential For
Adoptive Immunotherapy And Allodepletion.
Blood, 104(8), 2403-2409.
Mollee, P., Arthur, C., Hughes, T., Januszewicz,
H., Grigg, A., Bradstock, K., Wolf, M., Gibson,
J., Schwarer, A., Spencer, A., et al (2004).
Interferon-Alpha-2B And Oral Cytarabine
Ocfosfate For Newly Diagnosed Chronic
Myeloid Leukaemia. Annals of Oncology,
15(12), 1810-1815.
Foster, A., Forrester, K., Gottlieb, D., Barton, G.,
Romagnoli, J., Bradstock, K. (2004).
Large-Scale Expansion Of
Cytomegalovirus-Specific Cytotoxic T Cells In
Suspension Culture. Biotechnology and
Bioengineering, 85(2), 138-146. <a
href="http://dx.doi.org/10.1002/bit.10801">[Mor
e Information]</a>
Antonenas, V., Shaw, P., Bradstock, K. (2004).
Letter: Infusion of unwashed umbilical cord
blood stem cells after thawing for allogeneic
transplantation. Bone Marrow Transplantation,
34(8), 739.
Szer, J., Durrant, S., Schwarer, A., Bradstock,
K., Gibson, J., Arthur, C., To, L., Hughes, T.,
Raunow, H. (2004). Oral Versus Intravenous
Ganciclovir For The Prophylaxis Of
Cytomegalovirus Disease After Allogeneic Bone
Marrow Transplantation. Internal Medicine
Journal, 34(3), 98-101.
Thomas, X., Boiron, J., Huguet, F., Dombret, H.,
Bradstock, K., Vey, N., Kovacsovics, T.,
Delannoy, A., Fegueux, N., Fenaux, P., et al
(2004). Outcome Of Treatment In Adults With
Acute Lymphoblastic Leukemia: Analysis Of
The Lala-94 Trial. Journal of Clinical Oncology,
22(20), 4075-4086.
Grigg, A., Reynolds, J., McQuillan, A., Juneja,
S., Di Iulio, J., Hui, C., Smith, C., Kimber, R.,
Bradstock, K. (2004). Prognostic features for
response and survival in elderly patients with de
novo acute myeloid leukemia treated with
mitoxantrone and intermediate dose cytarabine.
Leukemia and Lymphoma, 46(3), 367-375.
Branford, S., Rudzki, Z., Parkinson, I., Grigg, A.,
Taylor, K., Seymour, J., Durrant, S., Browett, P.,
Schwarer, A., et, A., Bradstock, K. (2004).
Real-Time Quantitative Pcr Analysis Can Be
Used As A Primary Screen To Identify Patients
With Cml Treated With Imatinib Who Have
Bcr-Abl Kinase Domain Mutations. Blood,
104(9), 2926-2932.
Bendall, L., Nilsson, S., Khan, N., James, A.,
Bonnet, C., Lock, R., Papa, R., Bradstock, K.,
Gottlieb, D. (2004). Role of CD44 variant exon 6
in acute lymphoblastic leukaemia: association
with altered bone marrow localisation and
increased tumor burden. Leukemia, 18(7),
1308-1311.
Erdstein, A., Daas, P., Bradstock, K., Robinson,
T., Hertzberg, M. (2004). Tuberculosis In
Allogeneic Stem Cell Transplant Recipients: Still
A Problem In The 21St Century. Transplant
Infectious Disease (Print), 6(4), 142-146.
Bradstock, K., Gottlieb, D., Hertzberg, M.,
Kerridge, I. (2004). Unrelated cord blood
transplantation for haematological malignancies
in adults: results from Westmead BMT Service.
Haematology Society Association of Australia,
Annual Scientific Meeting, Melbourne, Victoria.
2003
Bendall, L., James, A., Zannettino, A., Simmons,
P., Gottlieb, D., Bradstock, K. (2003). A novel
CD44 antibody identifies an epitope that is
aberrantly expressed on acute lymphoblastic
leukaemia cells. Immunology and Cell Biology,
81(4), 311-319.
Favre, G., Beksac, M., Bacigalupo, A., Ruutu,
T., Nagler, A., Gluckman, E., Russell, N.,
Apperley, J., Szer, J., Bradstock, K., et al (2003).
Differences between graft product and donor side
effects following bone marrow or stem cell
Publications for Kenneth Bradstock
donation. Bone Marrow Transplantation, 32(9),
873-880.
Juarez, J., Gottlieb, D., Bradstock, K., Bendall,
L. (2003). Effects of inhibitors of the chemokine
receptor CXCR4 on acute lymphoblastic
leukemia cells in vitro. Leukemia, 17(7),
1294-1300.
Vuckovic, S., Kim, M., Khalil, D., Turtle, C.,
Crosbie, G., Williams, N., Brown, L., Williams,
K., Kelly, C., Stravos, P., Bradstock, K., et al
(2003). Granulocyte-colony stimulating factor
increases CD123hi blood dendritic cells with
altered CD62L and CCR7 expression. Blood,
101(6), 2314-2317.
Branford, S., Rudzki, Z., Harper, A., Grigg, A.,
Taylor, K., Durrant, S., Arthur, C., Browett, P.,
Schwarer, A., Ma, D., Bradstock, K., et al
(2003). Imatinib produces significantly superior
molecular responses compared to interferon alfa
plus cytarabine in patients with newly disgnosed
chronic myeloid leukemia in chronic phase.
Leukemia, 17(12), 2401-2409.
Zannettino, A., Roubelakis, M., Welldon, K.,
Jackson, D., Simmons, P., Bendall, L., Henniker,
A., Harrison, K., Niutta, S., Bradstock, K., et al
(2003). Novel mesenchymal and haematopoietic
cell isoforms of the SHP-2 docking receptor,
PZR: identification, molecular cloning and
effects on cell migration. Biochemical Journal,
370(2), 537-549.
Hertzberg, M., Crombie, C., Benson, W., Taper,
J., Gottlieb, D., Bradstock, K. (2003).
Outpatient-based ifosfamede, carboplatin and
etoposide (ICE) chemotherapy in
transplant-eligible patients with non-Hodgkin's
lymphoma and Hodgkin's disease. Annals of
Oncology, 14(Supplement 1), i11-i16.
Foster, A., Gottlieb, D., Marangolo, M., Bartlett,
A., Li, Y., Barton, G., Romagnoli, J., Bradstock,
K. (2003). Rapid, Large-Scale Generation of
Highly Pure Cytomegalovirus-Specific Cytotoxic
T Cells for Adoptive Immunotherapy. Stem Cells
and Development, 12(1), 93-105.
Lee, D., Chitturi, S., Kench, J., George, J.,
Fuller, S., Bradstock, K., Lin, R., Wong, K.,
Young, N. (2003). Transjugular liver biopsy
effecting changes in clinical management.
Journal of Medical Imaging and Radiation
Oncology, 47(2), 117-120. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=12780438">[More Information]</a>
2002
Saad, S., Gottlieb, D., Bradstock, K., Overall, C.,
Bendall, L. (2002). Cancer cell-associated
fibronectin induces release of matrix
metalloproteinase-2 from normal fibroblasts.
Cancer Research, 62, 283-289.
Foster, A., Gottlieb, D., Sartor, M., Hertzberg,
M., Bradstock, K. (2002).
Cytomegalovirus-specific CD4+ and CD8+
T-cells follow a similar reconstitution pattern
after allogeneic stem cell transplantation. Biology
of Blood and Marrow Transplantation, ,
501-511.
Hensel, N., Melenhorst, J., Bradstock, K.,
Schwarer, A., Eniafe, R., Nakamura, R., Barrett,
A. (2002). Flow cytometric quantitation and
characterization of the T-lymphocyte memory
response to CMV in healthy donors.
Cytotherapy, 4(1), 29-40.
Bosly, A., Keating, M., Stasi, R., Bradstock, K.
(2002). Rituximab in B-cell disorders other than
non-Hodgkin's lymphoma. Anti-Cancer Drugs,
13(supp 2), s25-s33.
Bradstock, K. (2002). The use of hematopoietic
growth factors in the treatment of acute
leukemia. Current Pharmaceutical Design, 8(5),
343-355.
Schmitz, N., Beksac, M., Hasenclever, D.,
Bacigalupo, A., Ruutu, T., Nagler, A.,
Gluckman, E., Russell, N., Apperley, J., Gorin,
N., Bradstock, K., et al (2002). Transplantation
of mobilized peripheral blood cells to
HLA-identical siblings with standard-risk
leukemia. Blood, 100(3), 761-767.
2001
Nivison-Smith, I., Bradstock, K., Szer, J.,
Durrant, S., Dodds, A., Hermann, R., Schwarer,
A., Gibson, J., To, L., Arthur, C. (2001).
Allogeneic haemopoietic cell transplants in
Australia, 1996--a multi-centre retrospective
comparison of the use of peripheral blood stem
cells with bone marrow. Bone Marrow
Transplantation, 28(1), 21-27.
Bradstock, K., Matthews, J., Young, G.,
Lowenthal, R., Baxter, H., Arthur, C., Bashford,
J., Enno, A., Brighton, T., Cannell, P., Gottlieb,
D., Joshua, D., et al (2001). Effects of
glycosylated recombinant human granulocyte
colony-stimulating factor after high-dose
cytarabine-based induction chemotherapy for
adult acute myeloid leukaemia. Leukemia, 15(9),
1331-1338.
Matthews, J., Bishop, J., Young, G., Juneja, S.,
Lowenthal, R., Garson, O., Cobcroft, R., Dodds,
A., Enno, A., Gillett, E., Bradstock, K., et al
(2001). Patterns of failure with increasing
intensification of induction chemotherapy for
acute myeloid leukaemia. British Journal of
Haematology, 113(3), 727-736.
Smith, A., Robson, L., St Heaps, L., Sharma, P.,
Dunlop, L., Bhave, A., Bradstock, K. (2001).
Publications for Kenneth Bradstock
Routine fluorescence in situ hybridization with
the MLL probe does not reliably detect two
separate signals on one chromosome 11 in
patients with trisomy 11. Cancer Genetics and
Cytogenetics, 129(2), 173-176.
Shen, W., Bendall, L., Gottlieb, D., Bradstock,
K. (2001). The chemokine receptor CXCR4
enhances integrin mediated in vitro adhesion and
facilitates engraftment of leukemic precursor-B
cells in the bone marrow. Experimental
Hematology, 29(12), 1439-1447.
Bradstock, K. (2001). Wanderings of the
bone-marrow stem cell. The Lancet, 358(9275),
5-6.
2000
Bradstock, K., Makrynikola, V., Bianchi, A.,
Shen, W., Hewson, J., Gottlieb, D. (2000).
Effects of the chemokine stromal cell-derived
factor-1 on the migration and localization of
precursor-B acute lymphoblastic leukemia cells
within bone marrow stromal layers. Leukemia,
14(5), 882-888.
Bendall, L., Bradstock, K., Gottlieb, D. (2000).
Expression of CD44 variant exons in acute
myeloid leukemia is more common and more
complex than that observed in normal blood,
bone marrow or CD34+ cells. Leukemia, 14(7),
1239-1246.
Nakase, K., Bradstock, K., Sartor, M., Gottlieb,
D., Byth Wilson, K., Kita, H., Shiku, H.,
Kamada, N. (2000). Geographic heterogeneity of
cellular characteristics of acute myeloid
leukemia: a comparative study of Australian and
Japanese adult cases. Leukemia, 14(1), 163-168.
Saad, S., Bendall, L., James, A., Gottlieb, D.,
Bradstock, K. (2000). Induction of matrix
metalloproteinases MMP-1 and MMP-2 by
co-culture of breast cancer cells and bone
marrow fibroblasts. Breast Cancer Research and
Treatment, 63(2), 105-115.